Melanoma (stage III or IV) - ipilimumab: updated analysis with revised patient access scheme from Bristol Myers-Squibb

Melanoma (stage III or IV) - ipilimumab: updated analysis with revised patient access scheme from Bristol Myers-Squibb

Melanoma (stage III or IV) - ipilimumab: updated analysis with revised patient access scheme from Bristol Myers-Squibb
02 November 2012
(1.54 Mb 39 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 31 October 2012